BACKGROUND: Streptococcus pneumoniae is a major cause of bacterial infections resulting in significant morbidity and mortality worldwide. Currently, up to 13 serotypes are included in pneumococcal conjugate vaccines (PCVs). However, the serotype formulation of these vaccines was initially designed to protect children against serotypes most commonly causing invasive disease in North America, and may not reflect the serotype distribution across the world. Data regarding pneumococcal epidemiology from the other parts of the world, in particular South East Asia, has not been reviewed. METHODS: This systematic literature review analyses published serotype data regarding S. pneumoniae isolates from South East Asian countries (defined as countries...
Although Streptococcus pneumoniae is a leading cause of childhood disease in South East Asia, little...
Streptococcus pneumoniae is the leading cause of bacterial infections worldwide and causes a range o...
Childhood vaccination with the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in Ca...
Background Streptococcus pneumoniae infection is associated with a high morbidity and mortality worl...
A number of pneumococcal carriage studies in children have been conducted in recent years. However, ...
A number of pneumococcal carriage studies in children have been conducted in recent years. However, ...
Pneumococcal disease, caused by the bacterium Streptococcus pneumoniae, is a major burden to global ...
Background: pneumococcal pneumonia is the leading cause of under-five mortality globally. The survei...
Background: Pneumococcal pneumonia is the leading cause of under-five mortality globally. The survei...
Pneumococcal infection is one of the leading causes of death worldwide, especially in children of de...
BACKGROUND:The 13-valent pneumococcal vaccine (PCV13) was introduced in Cambodia in January 2015. Th...
Background The 13-valent pneumococcal vaccine (PCV13) was introduced in Cambodia in January 2015. T...
Objective: This study was performed to analyze the serotype distribution of Streptococcus pneumoniae...
Background The 13-valent pneumococcal vaccine (PCV13) was introduced in Cambodia in January 2015. T...
Background: Streptococcus pneumoniae is an important cause of morbidity and mortality in Southeast A...
Although Streptococcus pneumoniae is a leading cause of childhood disease in South East Asia, little...
Streptococcus pneumoniae is the leading cause of bacterial infections worldwide and causes a range o...
Childhood vaccination with the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in Ca...
Background Streptococcus pneumoniae infection is associated with a high morbidity and mortality worl...
A number of pneumococcal carriage studies in children have been conducted in recent years. However, ...
A number of pneumococcal carriage studies in children have been conducted in recent years. However, ...
Pneumococcal disease, caused by the bacterium Streptococcus pneumoniae, is a major burden to global ...
Background: pneumococcal pneumonia is the leading cause of under-five mortality globally. The survei...
Background: Pneumococcal pneumonia is the leading cause of under-five mortality globally. The survei...
Pneumococcal infection is one of the leading causes of death worldwide, especially in children of de...
BACKGROUND:The 13-valent pneumococcal vaccine (PCV13) was introduced in Cambodia in January 2015. Th...
Background The 13-valent pneumococcal vaccine (PCV13) was introduced in Cambodia in January 2015. T...
Objective: This study was performed to analyze the serotype distribution of Streptococcus pneumoniae...
Background The 13-valent pneumococcal vaccine (PCV13) was introduced in Cambodia in January 2015. T...
Background: Streptococcus pneumoniae is an important cause of morbidity and mortality in Southeast A...
Although Streptococcus pneumoniae is a leading cause of childhood disease in South East Asia, little...
Streptococcus pneumoniae is the leading cause of bacterial infections worldwide and causes a range o...
Childhood vaccination with the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in Ca...